Cargando…
The history of respiratory disease management
Over the past 200 years lung diseases have shifted from infections – tuberculosis, pneumonia – to diseases of dirty air – chronic obstructive pulmonary disease, asthma and lung cancer. New diseases have emerged from industrial pollution and HIV infection, while better imaging has revealed others pre...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102619/ https://www.ncbi.nlm.nih.gov/pubmed/32288588 http://dx.doi.org/10.1016/j.mpmed.2020.01.007 |
_version_ | 1783511869867163648 |
---|---|
author | Geddes, Duncan |
author_facet | Geddes, Duncan |
author_sort | Geddes, Duncan |
collection | PubMed |
description | Over the past 200 years lung diseases have shifted from infections – tuberculosis, pneumonia – to diseases of dirty air – chronic obstructive pulmonary disease, asthma and lung cancer. New diseases have emerged from industrial pollution and HIV infection, while better imaging has revealed others previously unrecognized. Scientific advances in microbiology, imaging and clinical measurement have improved diagnosis and allowed better targeted treatment. Advances in treatment have been dramatic, the most important being drugs (antibiotics, cortisone, β(2)-adrenoceptor agonists), ventilatory support (from iron lung to nasal positive-pressure ventilation), inhaled therapy (metered dose inhalers, nebulizers) and lung surgery (resections, video-assisted thoracoscopic surgery, transplantation). Delivery of care has shifted from sanatoria for the rich but nothing at all for the poor, to universal coverage in both primary and hospital care. Generalists have turned into super-specialists and doctors have been joined by growing numbers of professions allied to medicine. Management of lung disease has vastly improved but the impact of disease remains. |
format | Online Article Text |
id | pubmed-7102619 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Published by Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71026192020-03-31 The history of respiratory disease management Geddes, Duncan Medicine (Abingdon) Clinical Aspects Over the past 200 years lung diseases have shifted from infections – tuberculosis, pneumonia – to diseases of dirty air – chronic obstructive pulmonary disease, asthma and lung cancer. New diseases have emerged from industrial pollution and HIV infection, while better imaging has revealed others previously unrecognized. Scientific advances in microbiology, imaging and clinical measurement have improved diagnosis and allowed better targeted treatment. Advances in treatment have been dramatic, the most important being drugs (antibiotics, cortisone, β(2)-adrenoceptor agonists), ventilatory support (from iron lung to nasal positive-pressure ventilation), inhaled therapy (metered dose inhalers, nebulizers) and lung surgery (resections, video-assisted thoracoscopic surgery, transplantation). Delivery of care has shifted from sanatoria for the rich but nothing at all for the poor, to universal coverage in both primary and hospital care. Generalists have turned into super-specialists and doctors have been joined by growing numbers of professions allied to medicine. Management of lung disease has vastly improved but the impact of disease remains. Published by Elsevier Ltd. 2020-04 2020-03-04 /pmc/articles/PMC7102619/ /pubmed/32288588 http://dx.doi.org/10.1016/j.mpmed.2020.01.007 Text en © 2020 Published by Elsevier Ltd. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Clinical Aspects Geddes, Duncan The history of respiratory disease management |
title | The history of respiratory disease management |
title_full | The history of respiratory disease management |
title_fullStr | The history of respiratory disease management |
title_full_unstemmed | The history of respiratory disease management |
title_short | The history of respiratory disease management |
title_sort | history of respiratory disease management |
topic | Clinical Aspects |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102619/ https://www.ncbi.nlm.nih.gov/pubmed/32288588 http://dx.doi.org/10.1016/j.mpmed.2020.01.007 |
work_keys_str_mv | AT geddesduncan thehistoryofrespiratorydiseasemanagement AT geddesduncan historyofrespiratorydiseasemanagement |